Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells

Leyi Yao(Guangdong Medical College), Jinbao Liu(State Key Laboratory of Respiratory Disease)
Cancer Biology and Medicine
May 24, 2022
Cited by 8


Related Papers

No related papers found

Powered by citation graph analysis